These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24133597)

  • 1. Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer.
    Fu M; Fan W; Pu X; Ni H; Zhang W; Chang F; Gong L; Xiong L; Wang J; Gu X
    Int J Clin Exp Pathol; 2013; 6(10):2185-91. PubMed ID: 24133597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.
    Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J
    Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
    Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
    Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High SHIP2 expression indicates poor survival in colorectal cancer.
    Yang J; Fu M; Ding Y; Weng Y; Fan W; Pu X; Ge Z; Zhan F; Ni H; Zhang W; Jin F; Xu N; Li J; Qiu L; Wang J; Gu X
    Dis Markers; 2014; 2014():218968. PubMed ID: 25525286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.
    Qin H; Ni Y; Tong J; Zhao J; Zhou X; Cai W; Liang J; Yao X
    Med Oncol; 2014 Aug; 31(8):142. PubMed ID: 25048725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
    Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
    Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
    Zhang M; Wen F; Zhao K
    J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
    Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
    Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
    Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
    Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
    Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
    Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
    Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.